Document is current
Any future updates will be listed below
-
Authors
Ito, Takanori https://orcid.org/0000-0002-2594-0854
Ishigami, Masatoshi
Yamamoto, Takafumi
Mizuno, Kazuyuki
Yamamoto, Kenta
Imai, Norihiro
Ishizu, Yoji
Honda, Takashi
Kawashima, Hiroki
Yasuda, Satoshi
Toyoda, Hidenori
Yokota, Kenji
Hase, Tetsunari
Nishio, Naoki
Maeda, Osamu
Kato, Masashi
Hashimoto, Naozumi
Hibi, Hideharu
Kodera, Yasuhiro
Sone, Michihiko
Ando, Yuichi
Akiyama, Masashi
Shimoyama, Yoshie
Fujishiro, Mitsuhiro
- License Information
-
More Information
Article History
Received: 30 April 2021
Accepted: 16 July 2021
First Online: 9 August 2021
Declarartions
:
: Y. H.: reports fees from AstraZeneca, Chugai Pharmaceutical Co. Ltd., Ono Pharmaceutical Co. Ltd., and Bristol-Myers Squibb Co., Y. A.: reports fees for lectures from Chugai, Pharmaceutical Co., Ltd., and commercial research funding from Chugai Pharmaceutical Co., Ltd. and Ono Pharmaceutical Co., Ltd. Takanori Ito, Masatoshi Ishigami, Takafumi Yamamoto, Kazuyuki Mizuno, Kenta Yamamoto, Norihiro Imai, Yoji Ishizu, Takashi Honda, Hiroki Kawashima, Satoshi Yasuda, Hidenori Toyoda, Kenji Yokota, Tetsunari Hase, Naoki Nishio, Osamu Maeda, Masashi Kato, Naozumi Hashimoto, Hideharu Hibi, Yasuhiro Kodera, Michihiko Sone, Masashi Akiyama, Yoshie Shimoyama, Mitsuhiro Fujishiro have nothing to disclose.
: The study protocol was approved by the Institutional Review Board at Nagoya University Hospital and Ogaki Municipal Hospital.
: Informed consent in the present study was obtained in the form of opt-out on the website.
: Not applicable.
: We agree with the policy in the journal.
